发明名称 |
Real time management of data relating to physiological control of glucose levels |
摘要 |
Continuous glucose monitoring (CGM) data and insulin delivery data are used to generate more reliable projected alarms related to a projected glucose levels. A memory stores endogenous data related to measurements of glucose level in a patient, and also stores exogenous data, such as insulin on board, both of which are used by a processor to create projected alarms. Profiles of CGM data are created for use in tuning patient-specific insulin data, such at basal rate, carb ratio, and insulin sensitivity. A processor searches for patterns in the data profiles and if found, recommended changes to patient-specific insulin data are provided to permit more accurate control over a patient's glucose levels. |
申请公布号 |
US8798934(B2) |
申请公布日期 |
2014.08.05 |
申请号 |
US201012842838 |
申请日期 |
2010.07.23 |
申请人 |
Abbott Diabetes Care Inc. |
发明人 |
Wei Charles;Hayter Gary A. |
分类号 |
G01N33/48;G01N31/00;G06G7/48;G06G7/58;A61B5/145;G06F19/00;A61M5/172;A61M5/142 |
主分类号 |
G01N33/48 |
代理机构 |
Jackson & Co., LLP |
代理人 |
Jackson & Co., LLP |
主权项 |
1. An integrated glucose management system for tuning patient-specific insulin data, comprising:
a memory configured to record and store glucose measurement data representing measurements of physiological glucose levels, and to store exogenous data in a form of attributes tagged to the stored glucose measurement data; a user interface comprising a visual display and an input device configured to receive and communicate user input data and instructions; and a processor comprising computer-executable instructions to:
record multiple series of glucose measurement data into the memory during defined time periods;tag each of the recorded series of glucose measurement data with exogenous attributes including a profile name, wherein the name of the profile is selected to identify the data recording as belonging to a particular category of patient conditions;access the memory to retrieve a plurality of profiles having a same profile name;compare the retrieved plurality of profiles to detect a persistent pattern of undesirable measured glucose levels existing in the plurality of profiles;provide an alarm at the user interface if the persistent pattern is detected in the retrieved plurality of profiles; andprovide a recommended change to patient-specific insulin data as a result of the detected persistent pattern, and display the recommended change on the user interface;wherein the computer-executable instructions include an excess insulin manager configured to provide a plurality of alternative recommended changes to the patient-specific insulin data; and furtherwherein the excess insulin manager is further configured to prioritize a recommended increase in carbohydrate intake lower than recommended changes to insulin delivery. |
地址 |
Alameda CA US |